In vivo engineering of CAR natural killer cells for immunotherapy using ligand-directed lipid nanoparticles

T1Covered by 1 source · first reported by Nature / Science / Nature Biotechnology at 13 Oct, 00:00 UTC

Nature Biotechnology, Published online: 13 October 2026; doi:10.1038/s41587-026-03310-1 Chimeric antigen receptor natural killer cells to treat autoimmune disease and cancer are generated in vivo.

Sources

• T1In vivo engineering of CAR natural killer cells for immunotherapy using ligand-directed lipid nanoparticlesNature / Science / Nature Biotechnology13 Oct, 00:00